GPX Medical
Every day, one in ten babies are born preterm, many of them with underdeveloped lungs that can advance to life-threatening conditions during their stay in the hospital and risk disabilities later on in life. They deserve a better start in life and health care professionals need support of modern technology to make life-changing decisions that can improve the health of these fragile patients.
GPX Medical’s groundbreaking innovation NEOLA® will upgrade today’s neonatal intensive care to include continuous lung monitoring and real-time alerts of life-threatening complications.
We are on a journey to revolutionize neonatal intensive care
Presentation of NEOLA
CEO of GPX Medical, Hanna Sjöström, presents NEOLA, a medical device for continuous monitoring of the lungs.
Lung monitoring with NEOLA
GPX Medicals’ proven technology uses laser spectroscopy to continuously measure lung volume changes and oxygen gas concentration in the lungs of preterm born infants. This is a safe and non-invasive method to monitor the lungs of these vulnerable patients in real time, providing the possibility of instant detection and treatment of complications and thus improving the care and decreasing the risk of disabilities later in life.
Latest News from GPX Medical
GPX Medical has Sold its First NEOLA® System to Tyndall National Institute at University College Cork to be used for a large Study on Newborn Infants within The Irish Centre for Maternal and Child Health Research in Ireland
Tyndall National Institute at University College Cork in Ireland (UCC) will...
VD presents GPX Medical’s quarterly report jan-sept 2020 + Q&A (English)
CEOr Hanna Sjöström presented today November 11th quarterly report January...
New Lund Technology to Save Premature Babies
GPX Medical is featured in an interview with Business in Lund: GPX Medical...
For Investors
We are on a journey to revolutionize neonatal intensive care
Learn more about investing in GPX Medical